In my third year at MSU, I started attending public lectures at RQC in Skolkovo. There, I found out about the website of Skolkovo Residents' vacancies. Then, I applied for an HPC C++ programmer at Quantum Pharmaceuticals. Even though I wasn't fit for that position, I was hired as an undergraduate researcher after a several-month internship. At that moment, the company just started a project on aging research. In a sense, I was so lucky to be one of the first employees working on aging. Slowly, our focus changed from a more traditional pharma to the aging and age-related diseases alone. We pivoted to aging, and started a new company, Gero. The field of aging research is rather young, mostly because the problem is so challenging that only in recent years people started to think about practically approaching it, and stopped thinking about aging as something technically inevitable. Thanks to the big data hype and advances in high-throughput omics biotechnologies, large biobanks (such as the UK BioBank) started gathering lots of data on public health and aging, which aging researchers are now using worldwide.
While working for Gero, I did an internship at one of the oldest Russian institutes studying aging, the Institute of Biology of the Russian Academy of Sciences. I got some experimental experience on studying aging in the model organism, the fruit fly, Drosophila melanogaster,
in the Laboratory of Molecular Radiobiology and Gerontology headed by Prof. Dr. Alexey Moskalev.
I've been working on different aspects of the problem of aging for almost 8 years by now. It took several years for me to adapt to the field's specifics, and start producing results. First, more theoretical ones
, and later, we managed to achieve non-trivial results in the practical life extension of C.elegans nematodes
. That paper attracted
a lot of attention, and was listed top-1 on Cell and Molecular Biology
in Scientific Reports in 2019.
In 2018-2019, Skoltech sponsored two of my trips to the U.S.: a 6-week internship at MIT, and a visit to the American Physical Society annual conference, where I presented the results related to my thesis. Also, while being in Boston, I gave a talk on aging at Harvard Medical School, and I guess it contributed a lot to the fact that some time ago, I received an invitation to do a postdoc at Harvard Medical School in the laboratory of Prof. Vadim Gladyshev, who has also been studying aging for a long time. We have already started a remote collaboration, and are currently working on several interesting aging problems